Oral cavity squamous cell carcinoma (OSCC) is a painful and debilitating cancer. Another PET/CT after surgery and before adjuvant therapy could improve survival for these patients, according to a study published in the Journal of Nuclear Medicine . {read more here}

Quantitative PET using agents like FDG could predict the outcome of chemotherapy for patients with particularly tricky cases of advanced breast cancer, according to a study published Dec. 4 in the Journal of Nuclear Medicine . {read more here}

Anti-angiogenic cancer treatments, which suppress the development of new vasculature, have emerged as a powerful way to stop or at least stymie cancer growth in select tumors. A novel PET technique combining a diagnostic radionuclide with a therapeutic agent can now map the potential results of therapy for advanced renal cell carcinoma, according to a study published Dec. 4 in the Journal of Nuclear Medicine . Preliminary results show substantial slowing of disease. {read more here}

PET/CT with Ga-68 DOTATATE has been found to change treatment plans in a majority of patients receiving initial evaluation and subsequent staging of neuroendocrine tumors (NETs), according to the results of two referring physician surveys published Dec. 11 in the Journal of Nuclear Medicine . {read more here}